Vivekanand Education Society’s College of Pharmacy Awarded ‘A’ Grade in QCI-NABET National Ranking 2025–2026
Mumbai: Vivekanand Education Society’s College of Pharmacy (Autonomous), Mumbai, has been ranked 5th nationally among pharmacy colleges offering undergraduate programmes in the Ranking & Rating of Pharmacy Colleges Offering Undergraduate Programmes (2025–2026). The ranking was conducted by the Quality Council of India (QCI)-National Accreditation Board for Education and Training (NABET) under the directives of the Pharmacy Council of India (PCI). In addition to this achievement, the institution has been awarded an ‘A’ Grade following a comprehensive evaluation across 11 assessment criteria.
Speaking on the achievement, Dr Supriya Shidhaye, Principal, VESCOP, said, “Receiving an ‘A’ Grade and being ranked among the top pharmacy institutions in the country is a proud milestone for VESCOP and a testament to the collective efforts of our faculty, students, researchers, alumni, and staff. This recognition reinforces our commitment to nurturing future-ready pharmacy professionals through academic excellence, innovation, and continuous quality enhancement.”
Dr Prakash Lulla, Trustee and Treasurer, VES, said, “VESCOP’s recognition as the 5th-ranked pharmacy college in India for undergraduate programmes, along with the award of an ‘A’ Grade, is a proud moment for the entire Vivekanand Education Society family. This achievement reflects the institution’s sustained focus on academic excellence, quality education, research, innovation, and the holistic development of students. We congratulate the leadership, faculty, students, researchers, alumni, and staff of VESCOP for their collective contribution to this milestone. At VES, we remain committed to strengthening our academic ecosystem and empowering future pharmacy professionals with the knowledge, skills, and values needed to contribute meaningfully to healthcare and society.”
As one of India’s leading pharmacy institutions, VESCOP remains committed to strengthening its academic and research capabilities while continuing to contribute meaningfully to the healthcare and pharmaceutical ecosystem through excellence in education, innovation, and societal impact.
